1.27
Health Sciences
How does opioid exposure affect brain development in young children?
How does opioid exposure affect brain development in young children?
That’s the question Allyson Mackey and Dylan Tisdall hope to answer, through a new grant from an NIH initiative focused on addiction research.
Kill stomach cancer risk by attacking this common bacteria
Kill stomach cancer risk by attacking this common bacteria
Penn researchers are the first to assess Helicobacter pylori infection and gastric cancer risk among certain demographics and ethnic groups.
Memory recall and spatial navigation elicit similar electrical activity in brain
Memory recall and spatial navigation elicit similar electrical activity in brain
Penn neuroscientists show for the first time that low-frequency oscillations called theta waves appear in both cases, a finding that could eventually help diminish memory loss.
Tweets from Twitter users could predict loneliness
Tweets from Twitter users could predict loneliness
By identifying similar themes across tweets, researchers are uncovering markers that could be used to predict loneliness, something that could lead to depression, heart disease, and dementia.
Complete remission within reach for rare autoimmune disease
Complete remission within reach for rare autoimmune disease
The findings may inform use of the recent FDA-approved drug rituximab to better treat patients with pemphigus, a rare chronic autoimmune condition.
Pushing medical science forward, with bioethics
Pushing medical science forward, with bioethics
Alongside Nursing Dean Antonia M. Villarruel, Penn President Amy Gutmann and PIK Professor Jonathan Moreno discussed their new book “Everybody Wants to Go to Heaven but Nobody Wants to Die” at the Smilow Center for Translational Research.
Advancing algorithmic care
Advancing algorithmic care
Experts from Penn share their perspectives on the role of advanced algorithms and AI in health care and what the future holds for digital health technologies.
A novel approach to treating opioid use disorder
A novel approach to treating opioid use disorder
An FDA-approved drug called exendin-4 decreased voluntary oxycodone taking and drug-seeking behavior during withdrawal in rats without reducing the relief the opioid provided.
Working hand in hand with the nation’s largest integrated care system
Working hand in hand with the nation’s largest integrated care system
In a unique partnership, Penn Nursing collaborates with the Veterans Health Administration on a range of issues, from pain management to end-of-life care.
Positive results in first-in-U.S. trial of CRISPR-edited immune cells
Positive results in first-in-U.S. trial of CRISPR-edited immune cells
Genetically editing a cancer patient’s immune cells using CRISPR/Cas9 technology, then infusing those cells back into the patient appears safe and feasible based on early data from the first-ever clinical trial to test the approach in humans in the United States.
In the News
Science
Deciphering a cancer treatment’s dark side
Saar Gill of the Perelman School of Medicine said it would be easier to treat cancer using CAR-T cell therapy without the looming possibility of triggering cytokine release syndrome.
FULL STORY →
The New York Times
Can melatonin vapes safely help people sleep?
Julio Chirinos of the Perelman School of Medicine wrote an editorial to accompany a new study about the effects of marathon running on the heart. “Exercise is great for the entire body, including the arteries,” he said.
FULL STORY →
Rolling Stone
Can melatonin vapes safely help people sleep?
Philip Gehrman of the Perelman School of Medicine commented on the use of melatonin to aid sleep. “There have been quite a few randomized trials showing that melatonin is no better than placebo to help people sleep,” he said.
FULL STORY →
“Academic Minute” (WAMC, Northeast Public Radio)
Jonathan Moreno on bioethics and the transformation of health care in America
PIK Professor Jonathan Moreno discussed the book “Everybody Wants to Go to Heaven but Nobody Wants to Die: Bioethics and the Transformation of Health Care in America,” which he co-authored with President Amy Gutmann.
FULL STORY →
The New York Times
The F.D.A. is in trouble. Here’s how to fix it
Steven Joffe of the Perelman School of Medicine spoke about the tensions between groups that want medical products to be proven effective before the F.D.A. approves them for public use and groups that believe patients can make their own decisions once the products pass basic safety testing. “The F.D.A. has been moving in the latter direction under great political and public pressure,” he said.
FULL STORY →